Browsing Tag
China
667 posts
CANbridge Pharmaceuticals begins CAN103 phase 1/2 trial in Gaucher disease
CANbridge Pharmaceuticals said that it has dosed the first patient in a phase 1/2 trial of CAN103 in…
July 21, 2022
HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms
HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in…
July 18, 2022
CANbridge doses first patient in phase 2 EMBARK study of CAN108 in BA
CANbridge Pharmaceuticals has dosed the first patient in the phase 2 EMBARK study of CAN108 (maralixibat) in biliary…
July 17, 2022
Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for…
February 20, 2022
G7 raises $200m for providing software for Chinese road freight industry
G7, a software service provider for the Chinese road freight industry, has raised $200 million in a new…
February 16, 2022
BMW AG increases stake in Chinese JV BMW Brilliance Automotive to 75%
Bayerische Motoren Werke Aktiengesellschaft (BMW AG) has acquired an additional stake of 25% in BMW Brilliance Automotive (BBA),…
February 13, 2022
Gazprom to supply additional gas to CNPC through Far Eastern route
Gazprom said that it has signed a long-term sales and purchase deal with China National Petroleum Corporation (CNPC)…
February 7, 2022
NOVATEK to supply LNG from Arctic LNG 2 project to ENN Natural Gas
NOVATEK said that its fully-owned subsidiary — NOVATEK Gas & Power Asia has inked a long-term LNG sale…
January 16, 2022
Zai Lab treats first patient in China in PANOVA-3 trial of TTFields
Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase…
January 15, 2022
Alphamab Oncology enrols patients for KN026-203 phase 2 clinical trial
Alphamab Oncology said that it has completed enrolling patients in China for its KN026-203 phase 2 clinical trial…
January 15, 2022